Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19

被引：18

作者：

Chistolini, Antonio ^{[1
]}

Ruberto, Franco ^{[2
]}

Alessandri, Francesco ^{[2
]}

Santoro, Cristina ^{[1
]}

Barone, Francesco ^{[1
]}

Cristina Puzzolo, Maria ^{[1
]}

Ceccarelli, Giancarlo ^{[3
]}

De Luca, Maria L. ^{[1
]}

Mancone, Massimo ^{[4
]}

Alvaro, Domenico ^{[5
]}

Pulcinelli, Fabio M. ^{[6
]}

Martelli, Maurizio ^{[1
]}

Foa, Robin ^{[1
]}

Pugliese, Francesco ^{[2
]}

机构：

[1] Sapienza Univ Rome, Dept Translat & Precis Med, Hematol, Rome, Italy

[2] Sapienza Univ Rome, Dept Gen Surg Surg Specialties & Organ Transplant, Rome, Italy

[3] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy

[4] Sapienza Univ Rome, Dept Clin Internal Med Anesthesiol & Cardiovasc S, Rome, Italy

[5] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy

[6] Sapienza Univ Rome, Dept Expt Med, Rome, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 04期

关键词：

COVID-19; thrombin generation assay; low-molecular-weight heparin;

D O I：

10.1111/bjh.17003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E214 / E218

页数：5

共 50 条

[31] Thrombin generation post elective caesarean section: Effect of low molecular weight heparin
Ismail, Siti K.
Norris, Lucy
Muttukrishna, Shanthi
Higgins, John R.
THROMBOSIS RESEARCH, 2012, 130 (05) : 799 - 803
[32] Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19
Gormez, S.
Gumusel, H. K.
Ekicibasi, E.
Degirmencioglu, A.
Paudel, A.
Akan, G.
Atalar, F.
Erdim, R.
Eroglu, E.
Dagdelen, S.
Sariguzel, N.
Kirisoglu, C. E.
Pamukcu, B.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2021, 122 (08): : 582 - 589
[33] Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinorna
von Delius, Stefan
Ayvaz, Muhammed
Wagenpfeil, Stefan
Eckel, Florian
Schmid, Roland M.
Lersch, Christian
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (02) : 434 - 439
[34] Use of low molecular weight heparin and hemoglobin fall in COVID-19 patients: A STROBE-compliant study
Hong, Ping-Yang
Huang, Mao-Hong
Hu, An-Ke
Lai, Yan-Ting
Zeng, Hui-Qing
Zhang, Xiao-Bin
MEDICINE, 2022, 101 (37) : E30367
[35] The effect of low-dose and high-dose low-molecular-weight-heparin and aspirin thromboprophylaxis on clinical outcome and mortality in critical ill patients with COVID-19 A retrospective cohort study
Eman, Ali
Balaban, Onur
Suner, Kezban O.
Cirdi, Yasar
Sahin, Fatih
Demir, Gurkan
Peksen, Ozge
Musmul, Ahmet
Erdem, Ali F.
SAUDI MEDICAL JOURNAL, 2022, 43 (07) : 715 - 722
[36] Rectus Sheath Hematoma Due to Low Molecular Weight Heparin in a COVID-19 Patient in Turkey
Kalayci, Tolga
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
[37] Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials
Ena, Javier
Valls, Victoria
CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (04) : 1189 - 1196
[38] Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials
Javier Ena
Victoria Valls
Clinical and Experimental Medicine, 2023, 23 (4) : 1189 - 1196
[39] Low molecular weight heparin is associated with better outcomes than unfractionated heparin for thromboprophylaxis in hospitalized COVID-19 patients: a meta-analysis
Alsagaff, Mochamad Yusuf
Mulia, Eka Prasetya Budi
Maghfirah, Irma
Azmi, Yusuf
Rachmi, Dita Aulia
Yutha, Alqi
Andira, Luqman Hakim
Semedi, Bambang Pujo
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (08) : 909 - 918
[40] Time to Recommend Heparin and Low-Molecular-Weight Heparins in Thromboprophylaxis in Medical-Surgical Critically III Patients
Volpi, Nicola
CRITICAL CARE MEDICINE, 2013, 41 (09) : 2224 - 2226

← 1 2 3 4 5 →